BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8406502)

  • 21. Cloning of novel Wilms tumor gene (WT1) cDNAs; evidence for antisense transcription of WT1.
    Eccles MR; Grubb G; Ogawa O; Szeto J; Reeve AE
    Oncogene; 1994 Jul; 9(7):2059-63. PubMed ID: 8208551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).
    Adachi Y; Matsubara S; Pedraza C; Ozawa M; Tsutsui J; Takamatsu H; Noguchi H; Akiyama T; Muramatsu T
    Oncogene; 1996 Nov; 13(10):2197-203. PubMed ID: 8950987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
    Rauscher FJ
    FASEB J; 1993 Jul; 7(10):896-903. PubMed ID: 8393820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM; Saunders GF
    Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
    Grubb GR; Yun K; Reeve AE; Eccles MR
    Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-specific regulation of the WT1 locus.
    Hewitt JA; Kessler PM; Campbell CE; Williams BR
    Med Pediatr Oncol; 1996 Nov; 27(5):456-61. PubMed ID: 8827074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion.
    Bardeesy N; Zabel B; Schmitt K; Pelletier J
    Genomics; 1994 Jun; 21(3):663-4. PubMed ID: 7959750
    [No Abstract]   [Full Text] [Related]  

  • 29. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural analysis of the human nov proto-oncogene and expression in Wilms tumor.
    Martinerie C; Huff V; Joubert I; Badzioch M; Saunders G; Strong L; Perbal B
    Oncogene; 1994 Sep; 9(9):2729-32. PubMed ID: 7520150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
    Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
    Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation.
    Malik KT; Wallace JI; Ivins SM; Brown KW
    Oncogene; 1995 Oct; 11(8):1589-95. PubMed ID: 7478583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1.
    Hamilton TB; Borel F; Romaniuk PJ
    Biochemistry; 1998 Feb; 37(7):2051-8. PubMed ID: 9485332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros.
    Bollig F; Perner B; Besenbeck B; Köthe S; Ebert C; Taudien S; Englert C
    Development; 2009 Sep; 136(17):2883-92. PubMed ID: 19666820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.
    Park S; Schalling M; Bernard A; Maheswaran S; Shipley GC; Roberts D; Fletcher J; Shipman R; Rheinwald J; Demetri G
    Nat Genet; 1993 Aug; 4(4):415-20. PubMed ID: 8401592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a clustered genomic organization of FAX-zinc finger protein encoding transcription units in Xenopus laevis.
    Nietfeld W; Conrad S; van Wijk I; Giltay R; Bouwmeester T; Knöchel W; Pieler T
    J Mol Biol; 1993 Mar; 230(2):400-12. PubMed ID: 8464056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain.
    Deuel TF; Guan LS; Wang ZY
    Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.